// App-Quantinova.ai

4987 : Role of the PD-1/PDL-1 pathway in resistance of patients with metastatic breast cancer to treatment with radiotherapy and TGF neutralization

Researchers

Presenter

  • Sandra Demaria

Principal Investigators

  • Claire Vanpouille-Box

  • Rachael E. Hawtin

  • Christie Fanton

  • Andy Conroy

  • Erik Evensen

  • Neha Dixit

  • Alan Barber

  • Dorthe Schaue

  • William H. McBride

  • Mary Helen Barcellos-Hoff

  • Silvia C. Formenti

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Nodality, South San Francisco, CA

  • UCLA, Los Angeles, CA

  • New York University School of Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

Drug/Treatment

  • Fresolimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved